Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Canadian-under $3.00 Stock-Picking Challenge -- Ignore unavailable to you. Want to Upgrade?

To: dsit who wrote (5919)	1/12/2002 9:08:20 AM
From: Al Collard	Respond to of 11802

Hi Dsit, Your in with RBM-v @$.70 for 14,285 shares. Chart for Response Biomedical Corp: stockcharts.com[l,a]dacaniay[pb50!c20][vc60][iLa12,26,9!Ll14] From the chart of RBM we can see the stock broke out last week, on a gap up, on well above average volume and is now trading above all it's major MA's. The chart indicators are bullish and the FDA approval of the company's medical device for the diagnosis of heart attacks should bode well for the stock in the short term. Good luck with this pick, **** Al

To: dsit who wrote (5919)	1/14/2002 3:55:07 PM
From: Al Collard	Respond to of 11802

RBM-v...in the news: Response to hold presentation on RAMP FDA clearance Mon 14 Jan 2002 Mr. John Gomez reports RESPONSE BIOMEDICAL TO HOLD INVESTOR PRESENTATION Response Biomedical, developer of the RAMP diagnostic system, advises that the company will hold an open presentation this Wednesday, Jan. 16, at 1:30 p.m. PT. At the presentation, Bill Radvak, president and chief executive officer of Response Biomedical, will discuss the impact of U.S. Food and Drug Administration (FDA) market clearance of the company's RAMP system, and Response's business strategy including sales timelines and projections. The meeting, open to the public and investment community, will be held at the Guinness Tower conference room in the lower mezzanine of 1055 West Hastings St., Vancouver, B.C. To attend, please RSVP to John Gomez by E-mail, jgomez@responsebio.com, or by telephone, (604) 681-4101, extension 218.